Hip Fractures

• 

  Subject Areas on Research

  • Advancing our diagnostic tools and treatment options for delirium. 
  • Age-related declines in activity level: the relationship between chronic illness and religious activities. 
  • An economic analysis of external hip protector use in ambulatory nursing facility residents. 
  • Analysis of past secular trends of hip fractures and predicted number in the future 2010-2050. 
  • Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture. 
  • Association between timing of zoledronic acid infusion and hip fracture healing. 
  • Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial. 
  • Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. 
  • Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users. 
  • Biomechanical evaluation of impaction fractures of the femoral head. 
  • Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? development and validation of a clinical tool. 
  • Cause specific mortality patterns among the oldest old: multiple cause of death trends 1968 to 1980. 
  • Changes on magnetic resonance images after traumatic hip dislocation. 
  • Clinical Fractures Among Older Men With Diabetes Are Mediated by Diabetic Complications. 
  • Clinical risk factors for recurrent fracture after hip fracture: a prospective study. 
  • Conversion vs Primary Total Hip Arthroplasty: Increased Cost of Care and Perioperative Complications. 
  • Correlation of hip fracture with other fracture types: Toward a rational composite hip fracture endpoint. 
  • Costs and outcomes of hip fracture and stroke, 1984 to 1994. 
  • Delirium detection and improved delirium management in older patients hospitalized for hip fracture. 
  • Determinants of postsurgical discharge setting for male hip fracture patients. 
  • Diagnostic accuracy of clinical tests of the hip: a systematic review with meta-analysis. 
  • Distribution and correlates of serum 25-hydroxyvitamin D levels in a sample of patients with hip fracture. 
  • Do estrogen or selective estrogen receptor modulators improve quality of life for women with postmenopausal osteoporosis? 
  • Effects of admission to a teaching hospital on the cost and quality of care for Medicare beneficiaries. 
  • Epidemiology of drug-disease interactions in older veteran nursing home residents. 
  • Experimental confirmation of the sheep model for studying the role of calcified fibrocartilage in hip fractures and tendon attachments. 
  • Expert physician recommendations and current practice patterns for evaluating and treating men with osteoporotic hip fracture. 
  • Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery - the SAVE-HIP3 study. 
  • Female urethral injuries associated with pelvic fracture: a systematic review of the literature. 
  • Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial. 
  • Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. 
  • Geriatric rehabilitation: state of the art. 
  • Hip Fracture in the Elderly Patients: A Sentinel Event. 
  • Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents. 
  • Hip arthroplasty after extracapsular hip fracture: a matched pair cohort analysis. 
  • Hip fracture outcomes: does surgeon or hospital volume really matter? 
  • Hip fracture rehabilitation. 
  • Hot Topics in Biomechanics: Hip Fracture Fixation. 
  • Images in clinical medicine. Occult hip fracture. 
  • Improving hip fractures outcomes for COPD patients. 
  • Inpatient Rehabilitation Outcomes in a National Sample of Medicare Beneficiaries With Hip Fracture. 
  • Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. 
  • Is hospital teaching status a key factor in hospital charge for children with hip fractures?: preliminary findings from KID database. 
  • Longitudinal change in clinical fracture incidence after initiation of bisphosphonates. 
  • Longitudinal incidence of adverse outcomes of age-related macular degeneration. 
  • Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. 
  • Meta-analysis: excess mortality after hip fracture among older women and men. 
  • Once-yearly zoledronic acid in older men compared with women with recent hip fracture. 
  • Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference. 
  • Performance-based outcomes of inpatient rehabilitation facilities treating hip fracture patients in the United States. 
  • Potential mediators of the mortality reduction with zoledronic acid after hip fracture. 
  • Predictors of length of hospital stay in elderly hip fracture patients. 
  • Preoperative Hypoalbuminemia Predicts Poor Short-term Outcomes for Hip Fracture Surgery. 
  • Regional anaesthesia versus general anaesthesia, morbidity and mortality. 
  • Regional anesthesia for trauma outside the operating theatre. 
  • Rehabilitation after hip fracture--equal opportunity for all? 
  • Relation between prefracture characteristics and perioperative complications in the elderly adult patient with hip fracture. 
  • Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture. 
  • Reproduction life history and hip fractures. 
  • Resident duty-hour reform associated with increased morbidity following hip fracture. 
  • Risk factors for hip fracture in skilled nursing facilities: who should be evaluated? 
  • Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. 
  • Self-Care and Mobility Following Postacute Rehabilitation for Older Adults With Hip Fracture: A Multilevel Analysis. 
  • Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEE. 
  • Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial. 
  • Subgroup variations in bone mineral density response to zoledronic acid after hip fracture. 
  • Subtrochanteric fractures in bisphosphonate-naive patients: results from the HORIZON-recurrent fracture trial. 
  • Surgery for hip fracture yields societal benefits that exceed the direct medical costs. 
  • Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States. 
  • The American Academy of Orthopaedic Surgeons Evidence-Based Guideline on Management of Hip Fractures in the Elderly. 
  • The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair. 
  • The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. 
  • The effect of comorbid illness on receipt of cancer screening by older people. 
  • The risk of subsequent fractures in community-dwelling men and male veterans with hip fracture. 
  • Thiazide diuretic agents and the incidence of hip fracture. 
  • Traumatic subchondral fracture of the femoral head: a case report. 
  • Treatment of comminuted subtrochanteric femoral fractures in a young population with a reconstruction nail. 
  • Update on the use of distal radial bone density measurements in prediction of hip and Colles' fracture risk. 
  • Weight-bearing asymmetry in individuals post-hip fracture during the sit to stand task. 
  • What is the role of timing in the surgical and rehabilitative care of community-dwelling older persons with acute hip fracture? 
  • Zoledronate, fractures, and mortality after hip fracture. 
  • Zoledronic acid and clinical fractures and mortality after hip fracture. 
  • Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON-Recurrent Fracture Trial. 
  • [Finite Element Analysis (FEA) for the structure capacity of proximal femur during falling--(II). The effects of falling configuration and load locations on the structural capacity of the proximal femur]. 
• 

  Keywords of People

  • Gold, Deborah T., Professor in Psychiatry and Behavioral Sciences, Psychology and Neuroscience
  • Olson, Steven Arthur, Professor of Orthopaedic Surgery, Orthopaedics
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics